Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Medadvisor Ltd

Healthcare AU MDR

NoneAUD
0.00(0%)

Last update at 2026-03-02T06:45:05.741481Z

Day Range

--
LowHigh

52 Week Range

0.020.17
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap14.00M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-11.44058M
  • Revenue TTM62.99M
  • Revenue Per Share TTM0.11
  • Gross Profit TTM 3.97M
  • Diluted EPS TTM-0.11

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -63.31166M 0.92M -10.51549M -17.72824M -17.22724M
Minority interest - - - 0.14M 0.40M
Net income -60.20898M 0.79M -11.30537M -17.34650M -13.94945M
Selling general administrative 9.49M 46.42M 41.47M 32.24M 24.43M
Selling and marketing expenses 1.21M 2.68M 3.26M 2.66M 2.24M
Gross profit 3.97M 23.63M 59.41M 34.99M 21.31M
Reconciled depreciation - 4.20M 5.35M 4.90M 3.21M
Ebit -13.05677M 2.85M -8.38164M -16.18605M -16.80515M
Ebitda -11.93275M 7.05M -3.02839M -11.28622M -13.59371M
Depreciation and amortization 1.12M 4.20M 5.35M 4.90M 3.21M
Non operating income net other - - - - -
Operating income -6.73283M 2.70M -7.03076M -16.18838M -18.32699M
Other operating expenses 69.73M 119.41M 106.40M 83.94M 55.63M
Interest expense 2.87M 1.93M 2.13M 1.54M 0.42M
Tax provision - 0.13M 0.79M -0.23983M -2.85525M
Interest income - 0.16M 0.05M 0.00233M 0.04M
Net interest income - -1.77337M -2.08235M -1.53986M -0.38351M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.00595M 0.13M 0.79M -0.23983M -2.85525M
Total revenue 62.99M 122.11M 97.96M 67.75M 38.77M
Total operating expenses 10.71M 20.93M 67.84M 53.15M 39.62M
Cost of revenue 59.02M 98.47M 38.55M 32.76M 17.47M
Total other income expense net -56.57883M -1.77337M -3.48474M -31.51089M 1.47M
Discontinued operations - - - - -
Net income from continuing ops - 0.79M -11.30537M -17.48841M -14.37199M
Net income applicable to common shares - 0.79M -11.30537M -17.34650M -13.94945M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 39.84M 98.78M 95.91M 78.44M 80.92M
Intangible assets - - 19.80M 18.96M 19.93M
Earning assets - - - - -
Other current assets 21.37M 2.08M 0.12M 0.12M 0.13M
Total liab 41.46M 47.20M 47.45M 43.89M 32.07M
Total stockholder equity -1.61774M 51.58M 48.46M 34.55M 48.45M
Deferred long term liab - - - - -
Other current liab 18.59M 14.65M 16.17M 16.30M 12.74M
Common stock 123.67M 116.55M 115.41M 91.81M 90.99M
Capital stock - - 115.41M 91.81M 90.99M
Retained earnings -132.29988M -72.09090M -72.88304M -61.57766M -44.23116M
Other liab - - 1.96M 0.67M 1.21M
Good will - 46.34M 46.61M 37.38M 34.62M
Other assets - 0.00000M 0.02M 0.14M 0.48M
Cash 10.30M 15.58M 14.20M 7.58M 7.15M
Cash and equivalents - - - - -
Total current liabilities 22.90M 45.67M 33.17M 35.26M 23.26M
Current deferred revenue - 15.14M 12.05M 7.51M 5.17M
Net debt 7.09M -2.97093M -1.10612M 5.84M 2.01M
Short term debt 0.08M 12.61M 0.78M 5.45M 1.57M
Short long term debt - - - 4.07M 0.30M
Short long term debt total 17.40M 12.61M 13.09M 13.41M 9.16M
Other stockholder equity - - -42.52859M -30.22996M -46.76132M
Property plant equipment - - 1.37M 3.47M 4.57M
Total current assets 39.50M 32.51M 28.11M 18.48M 21.32M
Long term investments - - - 0.13M 0.12M
Net tangible assets - - -17.94791M -21.80112M -6.09786M
Short term investments - - 0.12M 0.12M 0.13M
Net receivables 7.82M 14.86M 11.73M 9.05M 12.46M
Long term debt - - 12.05M 7.06M 6.09M
Inventory - - 2.06M 1.73M 1.58M
Accounts payable 4.22M 3.27M 4.17M 6.00M 3.79M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 7.01M 7.13M 5.93M 4.32M 1.69M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.02M 0.02M 0.02M 0.14M 0.48M
Deferred long term asset charges - - - - -
Non current assets total 0.34M 66.27M 67.80M 59.96M 59.60M
Capital lease obligations - - 1.05M 2.28M 2.77M
Long term debt total - - 12.31M 7.96M 7.60M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - -2.79629M -3.23047M -0.29079M -43.88620M
Change to liabilities - - 3.64M 7.68M -4.15322M
Total cashflows from investing activities -2.17885M -2.79629M -3.23047M -0.29079M -43.88620M
Net borrowings - - -1.23101M 1.92M 5.85M
Total cash from financing activities 11.34M -0.83196M 12.42M 1.86M 51.24M
Change to operating activities - - -0.47091M -0.27626M 0.18M
Net income -60.20898M 0.79M -11.30537M -17.34650M -13.94945M
Change in cash -5.27445M 1.38M 6.62M 0.43M -5.19430M
Begin period cash flow 15.58M 14.20M 7.58M 7.15M 12.35M
End period cash flow 10.30M 15.58M 14.20M 7.58M 7.15M
Total cash from operating activities -14.36522M 5.19M -1.45409M -0.23632M -12.54395M
Issuance of capital stock - - 14.60M - 47.53M
Depreciation 3.19M 4.20M 3.27M 3.09M 2.00M
Other cashflows from investing activities - -1.76866M - 0.02M -43.49409M
Dividends paid - - - 14.60M 6.78M
Change to inventory - - - - -
Change to account receivables - -3.01899M -1.78433M 3.41M -1.70456M
Sale purchase of stock - 0.00000M -0.94927M -0.05250M -2.44417M
Other cashflows from financing activities - -0.83196M -1.23101M 2.21M 13.15M
Change to netincome - - 2.57M 1.40M 3.87M
Capital expenditures 0.00000M 1.83M 0.18M 0.31M 0.39M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - -2.78203M -1.78433M 3.41M -1.70456M
Stock based compensation 1.83M 2.57M 2.20M 1.22M 1.28M
Other non cash items 40.82M 2.98M 6.58M 14.02M -0.59683M
Free cash flow -14.36522M 3.35M -1.63276M -0.54813M -12.93606M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
MDR
Medadvisor Ltd		 - -% - - 8.00 0.22 3.95 0.34 64.03
PME
Pro Medicus Ltd		 -0.4 0.25% 159.23 57.86 74.07 56.53 35.08 55.81 72.13
EIQ
Echoiq Ltd		 -0.01 0.75% 1.32 - - 9195.91 48.41 9072.58 -8.2701
AYA
ARTRYA Ltd		 0.11 2.36% 4.77 - - 25742.94 8.36 8076.24 0.33
CGS
Cogstate Ltd		 -0.01 0.40% 2.49 28.89 24.33 7.93 6.20 5.35 16.64

Reports Covered

Stock Research & News

View All

Profile

Adheris Health Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, the United States, and the United Kingdom. The company offers THRiV, an omni-channel platform which provides pharmacy-driven patient and pharmacist engagement solutions to improve medication management. The company was formerly known as MedAdvisor Limited and changed its anme to Adheris Health Limited in November 2025. The company was incorporated in 2010 and is based in Woburn, Massachusetts.

Medadvisor Ltd

100 TradeCenter, Woburn, MA, United States, 01801

Key Executives

Name Title Year Born
Ms. Ruba El-Afifi Chief Operating Officer NA
Mr. John Ciccio Chief Exec. Officer of Adheris NA
Mr. Rick Ratliff CEO, MD & Director NA
Ms. Ancila Desai B.Com., C.A., M.B.A. Chief Financial Officer NA
Mr. Craig Schnuriger Acting Chief Technology Officer NA
Ms. Naomi Lawrie Company Sec. & Gen. Counsel NA
Mr. Wayne Marinoff EGM of Sales & Marketing NA
Mr. Jamal Butt Chief Exec. Officer of UK NA
Mr. James M. Rotsart R.Ph. Exec. VP of US & Client Relations NA
Mr. Richard Ratliff CEO, MD & Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions